KevinMarkSlawinMD
Urology • Bal Harbour, FLMinimally Invasive Surgery, Surgical Oncology, Clinical Pharmacology
Biotechnology Founder, Investor and Entrepreneur, Founder and Managing Partner, Rapha Capital Management LLC, Founder, Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), Founder and CEO, Ponce Therapeutics, Inc. (https://poncethera.com), Founder and CEO, Deliver Therapeutics, Inc. (https://deliverthera.com), Chairman and CEO, PrintBio, Inc. (https://printbio.com)
Dr. Slawin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9511 Collins Avenue
#1403
Bal Harbour, FL 33154Phone+1 305-809-6920Fax+1 305-675-3972- Is this information wrong?
Summary
- No longer in practice, I manage an investment advisory in early stage biotech named Rapha Capital Management (https://raphacap.com). I’m also the Founder and CEO, Ponce Therapeutics, Inc. and Deliver Therapeutics, Inc., both located at K2 Bio in Houston, TX, and using advanced technologies in novel ways to develop the first therapeutics to arrest or reverse aging.
Education & Training
Baylor College of MedicineFellowship, Minimally Invasive Urologic Surgery, 1992 - 1994
New York Presbyterian Hospital (Columbia Campus)Residency, Urology, 1988 - 1992
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Surgery, 1986 - 1988
Columbia University Vagelos College of Physicians and SurgeonsClass of 1986
Certifications & Licensure
FL State Medical License 2018 - 2025
NY State Medical License 1986 - 2022
TX State Medical License 1993 - 2019
Awards, Honors, & Recognition
- F. Brantley Scott, Jr., Award for Innovation and Creativity in Urology. Scott Dept. of Urology, Baylor College of Medicine, 2003
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors:SE Texas Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Medical Therapy of Prostatic Symptoms Start of enrollment: 1995 Dec 01
- A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology Start of enrollment: 2012 Aug 01
Publications & Presentations
PubMed
- 53 citationsTwo-Dimensional Regulation of CAR-T Cell Therapy with Orthogonal Switches.My Linh T. Duong, Matthew R. Collinson-Pautz, Eva Morschl, An Lu, Slawomir P. Szymanski, Ming Zhang, Mary E. Brandt, Wei-Chun Chang, Kelly L. Sharp, Steven M. Toler, K...> ;Molecular Therapy Oncolytics. 2019 Mar 29
- 50 citationsConstitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies.Matthew R. Collinson-Pautz, Wei-Chun Chang, An Lu, Mariam Khalil, Jeannette Crisostomo, Pei-Yi Lin, Aruna Mahendravada, Nicholas P. Shinners, Mary E. Brandt, Ming Zhan...> ;Leukemia. 2019 Feb 28
- 75 citationsRegulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40Aaron E. Foster, Aruna Mahendravada, Nicholas P. Shinners, Wei-Chun Chang, Jeannette Crisostomo, An Lu, Mariam Khalil, Eva Morschl, Joanne L. Shaw, Sunandan Saha, My L...> ;Molecular Therapy. 2017 Sep 6
- Join now to see all
Journal Articles
- A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-S...John P Mulhall, Eric A Klein, Kevin Slawin, Peter T Scardino, The Journal of Sexual Medicine
Press Mentions
Rapha Capital Management Launches $100M Life Science VC Fund with an Eye on Early ScienceApril 16th, 2021- AHA, Children’s Heart Foundation Award Funds to Research in Congenital Heart DefectsFebruary 13th, 2021
- Biopharmaceutical Company AsclepiX Therapeutics Raises $35 MillionJune 29th, 2020
- Join now to see all
Industry Relationships
- Board Member, 3DBio, Inc2019 - Present
- Founder and Managing Partner, Rapha Capital Management, LLC2018 - Present
- Board Member, AsclepiX Therapeutics2018 - Present
- Founder, Bellicum Pharmaceuticals, Inc.2004 - Present
External Links
- Rapha Capital Management LLChttp://raphacap.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
